(Q82035590)
Statements
A phase II trial of erlotinib as front-line treatment in clinically selected patients with non-small-cell lung cancer (English)
Athanasios G Pallis
Alexandra Voutsina
Nikolaos Kentepozidis
Stylianos Giassas
Pavlos Papakotoulas
Kostas Tryfonidis
Athanasios Kotsakis
Lambros Vamvakas
Nikolaos Vardakis
Vassilis Georgoulias